These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

650 related articles for article (PubMed ID: 11303834)

  • 1. Non-type b Haemophilus influenzae disease: clinical and epidemiologic characteristics in the Haemophilus influenzae type b vaccine era.
    Heath PT; Booy R; Azzopardi HJ; Slack MP; Fogarty J; Moloney AC; Ramsay ME; Moxon ER
    Pediatr Infect Dis J; 2001 Mar; 20(3):300-5. PubMed ID: 11303834
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pediatric invasive Haemophilus influenzae infections in Israel in the era of Haemophilus influenzae type b vaccine: a nationwide prospective study.
    Bamberger EE; Ben-Shimol S; Abu Raya B; Katz A; Givon-Lavi N; Dagan R; Srugo I;
    Pediatr Infect Dis J; 2014 May; 33(5):477-81. PubMed ID: 24445822
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Antibody concentration and clinical protection after Hib conjugate vaccination in the United Kingdom.
    Heath PT; Booy R; Azzopardi HJ; Slack MP; Bowen-Morris J; Griffiths H; Ramsay ME; Deeks JJ; Moxon ER
    JAMA; 2000 Nov; 284(18):2334-40. PubMed ID: 11066183
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A nationwide population-based surveillance of invasive Haemophilus influenzae diseases in children after the introduction of the Haemophilus influenzae type b vaccine in Japan.
    Suga S; Ishiwada N; Sasaki Y; Akeda H; Nishi J; Okada K; Fujieda M; Oda M; Asada K; Nakano T; Saitoh A; Hosoya M; Togashi T; Matsuoka M; Kimura K; Shibayama K
    Vaccine; 2018 Sep; 36(38):5678-5684. PubMed ID: 30122645
    [TBL] [Abstract][Full Text] [Related]  

  • 5.
    Slack M; Esposito S; Haas H; Mihalyi A; Nissen M; Mukherjee P; Harrington L
    Expert Rev Vaccines; 2020 Oct; 19(10):903-917. PubMed ID: 32962476
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Vaccine failures after primary immunisation with Haemophilus influenzae type-b conjugate vaccine without booster.
    Booy R; Heath PT; Slack MP; Begg N; Moxon ER
    Lancet; 1997 Apr; 349(9060):1197-202. PubMed ID: 9130940
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clinical and immunological risk factors associated with Haemophilus influenzae type b conjugate vaccine failure in childhood.
    Heath PT; Booy R; Griffiths H; Clutterbuck E; Azzopardi HJ; Slack MP; Fogarty J; Moloney AC; Moxon ER
    Clin Infect Dis; 2000 Oct; 31(4):973-80. PubMed ID: 11049779
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Incidence of radiologically-confirmed pneumonia and Haemophilus influenzae type b carriage before Haemophilus influenzae type b conjugate vaccine introduction in Central Vietnam.
    Yoshida LM; Nguyen HA; Watanabe K; Le MN; Nguyen AT; Vu HT; Yoshino H; Suzuki M; Takahashi K; Le T; Moriuch H; Kilgore PE; Edmond K; Mulholland K; Dang DA; Ariyoshi K
    J Pediatr; 2013 Jul; 163(1 Suppl):S38-43. PubMed ID: 23773592
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effectiveness of Haemophilus influenzae type b Conjugate vaccine introduction into routine childhood immunization in Kenya.
    Cowgill KD; Ndiritu M; Nyiro J; Slack MP; Chiphatsi S; Ismail A; Kamau T; Mwangi I; English M; Newton CR; Feikin DR; Scott JA
    JAMA; 2006 Aug; 296(6):671-8. PubMed ID: 16896110
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Invasive Haemophilus influenzae disease in Utah children: an 11-year population-based study in the era of conjugate vaccine.
    Bender JM; Cox CM; Mottice S; She RC; Korgenski K; Daly JA; Pavia AT
    Clin Infect Dis; 2010 Apr; 50(7):e41-6. PubMed ID: 20178414
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A nationwide prospective surveillance study in Israel to document pediatric invasive infections, with an emphasis on Haemophilus influenzae type b infections. Israeli Pediatric Bacteremia and Meningitis Group.
    Dagan R; Fraser D; Greif Z; Keller N; Kaufstein M; Shazberg G; Schlesinger M
    Pediatr Infect Dis J; 1998 Sep; 17(9 Suppl):S198-203. PubMed ID: 9781763
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Paediatric acute epiglottitis: not a disappearing entity.
    McEwan J; Giridharan W; Clarke RW; Shears P
    Int J Pediatr Otorhinolaryngol; 2003 Apr; 67(4):317-21. PubMed ID: 12663101
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Haemophilus influenzae type b disease among children in rural Mozambique: impact of vaccine introduction.
    Sigaúque B; Vubil D; Sozinho A; Quintó L; Morais L; Sacoor C; Carvalho MG; Verani JR; Alonso PL; Roca A
    J Pediatr; 2013 Jul; 163(1 Suppl):S19-24. PubMed ID: 23773589
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of Haemophilus influenzae type b vaccination without a booster dose on invasive H influenzae type b disease, nasopharyngeal carriage, and population immunity in Kilifi, Kenya: a 15-year regional surveillance study.
    Hammitt LL; Crane RJ; Karani A; Mutuku A; Morpeth SC; Burbidge P; Goldblatt D; Kamau T; Sharif S; Mturi N; Scott JA
    Lancet Glob Health; 2016 Mar; 4(3):e185-94. PubMed ID: 26853149
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Invasive Haemophilus influenzae type b disease in England and Wales: who is at risk after 2 decades of routine childhood vaccination?
    Collins S; Ramsay M; Campbell H; Slack MP; Ladhani SN
    Clin Infect Dis; 2013 Dec; 57(12):1715-21. PubMed ID: 24076970
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Invasive infections caused by haemophilus influenzae serotypes in twelve Canadian IMPACT centers, 1996-2001.
    McConnell A; Tan B; Scheifele D; Halperin S; Vaudry W; Law B; Embree J;
    Pediatr Infect Dis J; 2007 Nov; 26(11):1025-31. PubMed ID: 17984810
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Epidemiology of Haemophilus influenzae type b disease and impact of Haemophilus influenzae type b conjugate vaccines in the United States and Canada.
    Wenger JD
    Pediatr Infect Dis J; 1998 Sep; 17(9 Suppl):S132-6. PubMed ID: 9781746
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Changing socioeconomic risk factors for invasive H. influenzae disease after the introduction of conjugate vaccine.
    Olowokure B; Spencer NJ; Hawker JI; Blair I; Smith RL
    J Infect; 2003 Jan; 46(1):46-8. PubMed ID: 12504608
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Haemophilus influenzae type b disease: impact and effectiveness of diphtheria-tetanus toxoids-acellular pertussis (-inactivated poliovirus)/H. influenzae type b combination vaccines.
    Schmitt HJ; von Kries R; Hassenpflug B; Hermann M; Siedler A; Niessing W; Clemens R; Weil J
    Pediatr Infect Dis J; 2001 Aug; 20(8):767-74. PubMed ID: 11734739
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Burden of invasive disease caused by Haemophilus influenzae type b in Bamako, Mali: impetus for routine infant immunization with conjugate vaccine.
    Sow SO; Diallo S; Campbell JD; Tapia MD; Keita T; Keita MM; Murray P; Kotloff KL; Levine MM
    Pediatr Infect Dis J; 2005 Jun; 24(6):533-7. PubMed ID: 15933564
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 33.